Advertisement
Screener

MANNKIND CORP (MNKD) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

MANNKIND CORP Cash Flow Breakdown

Cash flow breakdown shows where MANNKIND CORP's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $18.25M came in.
  • Fiscal year ended 2025-12-31: from investing, $304.80M went out.
  • Fiscal year ended 2025-12-31: from financing, $315.10M came in.
  • Fiscal year ended 2025-12-31: change in cash, $28.55M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31$18.25M-$304.80M$325.00M$6.40M-$16.30M*$28.55M
2024-12-31$42.51M-$96.65M$2.90M-$140.17M*-$191.40M
2023-12-31$34.09M-$1.99M$1.20M$135.41M*$168.71M
2022-12-31-$80.68M$4.87M$3.00M$18.39M*-$54.42M
2021-12-31-$61.71M-$151.54M$1.00M$269.27M*$57.02M
2020-12-31-$28.13M$15.22M$4.87M$10.00M$600.00K$34.38M*$36.94M
2019-12-31-$88.48M-$22.84M$33.08M*$100.00K$36.68M*-$41.46M
2018-12-31-$37.73M-$234.00K-$5.00M$430.00K$7.00K$65.86M*$23.33M
2017-12-31-$64.78M$16.68M-$4.00M-$127.00K$564.00K$24.00K$77.10M*$25.46M
2016-12-31-$78.09M-$1.13M-$5.00M-$165.00K$893.00K$47.31M*-$36.18M
2015-12-31-$57.23M-$10.20M-$64.29M-$1.86M$28.39M$40.00K$43.38M*-$61.77M
2014-12-31$4.09M-$24.10M$20.00M-$26.91M$76.97M*$50.05M
2013-12-31-$128.73M-$7.99M-$115.00M$119.50M-$4.80M$49.99M$95.98M*$8.95M
2012-12-31-$119.86M-$560.00K-$906.00K$180.49M*$59.16M
2011-12-31-$123.84M-$2.94M$63.39M*-$63.38M
2010-12-31-$148.65M-$11.72M$196.42M*$36.04M
2009-12-31-$184.08M-$3.05M$189.51M*$2.37M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30-$18.37M*$17.91M*$200.00K*
2026-03-31-$5.37M$18.73M$300.00K-$35.71M*-$22.05M
2025-12-31-$7.96M*-$291.96M*$250.00M*$0.00*-$2.59M*
2025-09-30$23.64M*-$25.06M*$100.00K*$71.71M*
2025-06-30$8.95M*$6.26M*-$5.51M*
2025-03-31-$6.38M$5.96M$1.39M*$975.00K
2024-12-31$22.64M*$48.22M*$0.00*-$86.90M*
2024-09-30$9.33M*-$41.26M*$0.00*-$2.34M*
2024-06-30$3.83M*-$55.18M*$0.00*-$44.55M*
2024-03-31$6.70M-$48.44M$1.40M-$4.87M*-$45.21M
2023-12-31$21.68M*-$7.89M*$0.00*$141.68M*
2023-09-30$8.66M*-$11.55M*$0.00*
2023-06-30$2.60M*$3.66M*-$5.95M*
2023-03-31$1.16M$13.79M$1.15M*$16.10M
2022-12-31-$2.38M*$15.01M*$16.00K*$2.81M*
2022-09-30-$28.07M*$27.35M*$0.00*$19.53M*
2022-06-30-$31.98M*$2.02M*$0.00*-$1.78M*
2022-03-31-$18.25M-$39.51M$684.00K-$56.94M
2021-12-31-$12.35M*-$12.58M*$0.00*-$6.00K*$97.38M*
2021-09-30-$15.18M*$4.99M*$0.00*$100.00K-$690.00K*
2021-06-30-$21.45M*-$112.53M*$100.00K-$51.59M*
2021-03-31-$12.73M-$31.42M$0.00$224.98M*$180.83M
2020-12-31$235.00K*-$4.48M*$0.00*$201.00K*$18.49M*
2020-09-30-$13.46M*-$4.00K*$0.00*$0.00$2.64M*
2020-06-30-$3.68M*-$150.00K*$28.19M*
2020-03-31-$11.22M$19.85M$8.96M
2019-12-31-$5.11M*-$202.00K*$0.00*$50.00K*$4.99M*
2019-09-30-$52.05M*$3.76M*-$4.42M*$32.00K*$69.88M*
2019-06-30-$19.73M*-$1.37M*-$676.00K*
2019-03-31-$11.60M-$25.03M$3.00K-$36.63M
2018-12-31$24.99M*-$244.00K*-$3.00M*$95.00K*$38.87M*
2018-09-30-$13.92M*$0.00*$0.00*-$1.82M*
2018-06-30-$27.15M*-$103.00K*$0.00*$26.73M*
2018-03-31-$21.65M-$81.00K$634.00K-$21.12M
2017-12-31-$29.98M*$0.00*$0.00*-$17.00K*$58.26M*
2017-09-30-$23.27M*$0.00*$0.00*-$22.00K*-$23.29M*
2017-06-30-$20.03M*$24.00K*-$13.00K*$15.43M*-$4.59M*
2017-03-31$8.51M$16.65M-$75.00K$25.08M
2016-12-31-$12.75M*$0.00*$0.00*-$4.00K*-$12.63M*
2016-09-30-$23.07M*$0.00*-$158.00K*-$4.97M*-$28.20M*
2016-06-30-$11.51M*$0.00*$0.00*$47.59M*$36.08M*
2016-03-31-$30.76M-$1.13M-$3.00K-$31.42M
2015-12-31-$22.55M*-$312.00K*$0.00*-$25.00K*$13.86M*$0.00*$35.18M*$26.15M*
2015-09-30-$19.89M*-$1.15M*-$1.01M*$12.49M*$0.00*-$64.68M*-$74.26M*
2015-06-30-$17.81M*-$4.53M*-$56.00K*$8.74M*-$13.66M*
2015-03-31$3.02M-$4.20M-$762.00K$1.95M*$3.00K
2014-12-31-$35.74M*-$14.21M*$0.00*-$64.00K*-$1.60M*-$51.62M*
2014-09-30$100.24M*-$217.00K*$0.00*-$26.72M*$57.95M*$131.25M*
2014-06-30-$23.42M*-$8.26M*-$90.00K*$37.22M*$5.46M*
2014-03-31-$36.99M-$1.41M-$33.00K$3.40M*-$35.03M
2013-12-31-$34.05M*-$6.17M*$40.00M*-$2.71M*-$20.09M*-$23.01M*
2013-09-30-$32.91M*-$230.00K*-$1.65M*$100.06M*$65.27M*
2013-06-30-$29.74M*-$132.00K*-$21.00K*$30.42M*$524.00K*
2013-03-31-$32.03M-$1.46M-$427.00K-$33.84M
2012-12-31-$28.10M*-$61.00K*$88.23M*$60.08M*
2012-09-30-$34.26M*-$124.00K*$4.51M*-$29.87M*
2012-06-30-$25.02M*-$84.00K*-$24.72M*
2012-03-31-$32.49M-$291.00K$86.45M*$53.67M
2011-12-31-$20.36M*-$125.00K*-$20.11M*
2011-09-30-$36.03M*-$594.00K*$34.65M*-$1.98M*
2011-06-30-$36.74M*-$4.05M*$18.65M*-$22.14M*
2011-03-31-$30.70M$1.83M$9.72M*-$19.15M
2010-12-31-$38.97M*-$8.11M*$15.22M*-$31.87M*
2010-09-30-$34.85M*$445.00K*$103.97M*$69.57M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19